Answers are grounded in this paper and cite their sources.
Near-infrared (NIR) laser-induced photothermal ablation (PTA) therapy has great potential to revolutionize conventional therapeutic approaches for cancers, and a prerequisite is to obtain biocompatible and efficient photothermal agents. Herein, we have developed hydrophilic W18O49 nanowires with average lengths of about 800 nm (abbreviated as W18O49-800 NWs) as an efficient photothermal agent, which are prepared by the solvothermal synthesis—simultaneous PEGylation/exfoliation/breaking two-step route. These W18O49-800 NWs exhibit stronger NIR photoabsorption than short nanowires with average lengths of about 50 nm (abbreviated as W18O49-50 NWs) that are prepared via a solvothermal one-step route. Under irradiation of 980 nm with a safe intensity of 0.72 W cm−2, the aqueous dispersion of W18O49-800 NWs (1.0 mg mL−1) exhibits the temperature elevation by 35.2 °C in 5 min; which is a 37.5% increase compared to that (by 25.6 °C) from W18O49-50 NWs (1.0 mg mL−1). More importantly, under 980 nm laser irradiation (0.72 W cm−2) for 10 min, in vivo cancer cells can be efficiently ablated by the photothermal effects of W18O49-800 NWs. Therefore, these W18O49-800 NWs can be used as a more efficient and promising photothermal nanoagent for the ablation of cancer cells in vivo.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: